Results of the final analysis of the ABEL Phase II clinical trial


No votes yet
 
Related
Sustained-release drug delivery is a field where significant progress is being made that increases the efficacy of the medicines, improves...
3 min
24/11/2022
TO THE SPANISH NATIONAL SECURITIES MARKET COMMISSION (COMISIÓN NACIONAL DEL MERCADO DE VALORES) Madrid, 23 November 2022 In...
1 min
23/11/2022
ROVI reports operating revenue growth of 24% and EBITDA growth of 25% • Operating revenue increased by 24% to 575.5 million euros driven...
3 min
04/11/2022